25.09.2012 • News

BASF to Boost Production Capacity for Fungicides in Germany and the US

BASF is making an investment of more than €200 million to scale up and further integrate production and formulation capacities in order to meet continued demand for several key fungicides, including F 500 and Xemium.

The investment drives significant expansions at facilities in Schwarzheide and Ludwigshafen, Germany, as well as Sparks, Georgia, USA. These measures will increase production capacity, flexibility and efficiency. It is one of the division's largest capital investments in recent years.

BASF aims for a peak sales potential of more than €200 million with Xemium, based on planned global launch plans in more than 50 countries for over 100 crops.The estimated peak sales potential for F 500 was raised to more than €1 billion earlier this year.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read